April 03, 2020
A candidate vaccine delivered though a thumbnail-sized patch studded with microneedles could help address the coronavirus disease 2019 (COVID-19) pandemic.
March 24, 2020
Despite more than 100 years of dedicated research, tuberculosis is still the world’s leading cause of death from a single infectious disease. To mark World TB Day this year, we at NIAID again join the world’s public health organizations in declaring that “It’s Time” to consign tuberculosis to the history books by conducting the research needed to end this disease.
February 20, 2020
Each February, NIH observesRare Disease Day to raise awareness about rare diseases, the people they affect, and scientific research. Every day of the year, researchers at NIAID and NIAID-funded institutions collaborate with patients and their families to better understand, diagnose, and treat a spectrum of rare conditions—from immune deficiencies to infectious diseases.
February 19, 2020
NIAID scientists working with investigators from the University of Texas at Austin identified the atomic structure of an important protein on the surface of the novel coronavirus (SARS-CoV-2, formerly called 2019-nCoV). The findings appear in the peer-reviewed journal Science.
February 13, 2020
NIAID has produced images of the novel coronavirus SARS-CoV-2 on its scanning and transmission electron microscopes on Tuesday, Feb. 11, 2020. SARS-CoV-2 causes COVID-2019 disease, which has grown to be a global public health emergency since cases were first detected in Wuhan, China, in December 2019.
November 26, 2019
Could bacteria that live in the guts of tiny parasitic roundworms be the source of new antibiotics capable of treating infections caused by the nastiest superbugs? Research by NIAID-supported scientists suggests the answer is yes.
October 25, 2019
In recent months, an uptick in cases of eastern equine encephalitis virus (EEEV) infections in Connecticut, Massachusetts, Michigan, and elsewhere in the United States has raised alarm. At NIAID, researchers are working to develop both vaccines and therapeutics to fight this rare but deadly virus.
IDWeek: Postnatal Zika Virus Infection in Children Does Not Impact Neurological Development, Study Finds
October 08, 2019
Although the Zika virus can have severe impacts on the neurological development of fetuses, its potential impact on older children, infected after birth, has been less clear. Happily, according to a NIAID-supported study presented at IDWeek 2019, postnatal Zika virus infection does not appear to negatively impact children’s neurological development.
October 02, 2019
At the October 2019 IDWeek meeting in Washington, D.C., NIAID-supported researchers added new details to an emerging picture about acute flaccid myelitis.
September 25, 2019
Fungal infections can be difficult to diagnose, leading to many missed and misdiagnosed cases. NIAID-supported researcher Dr. Sophia Koo from Brigham and Women’s Hospital in Boston is developing a breath-based diagnostic for fungal pathogens that can detect molecular signatures or biomarkers that indicate the presence of a fungal infection.
August 28, 2019
NIAID-funded researchers can use viral genomes to trace the spread of the Zika virus, and uncover outbreaks that were previously undetected.
July 30, 2019
Researchers investigate the puzzling phenomenon of why mosquitoes prefer to bite some people over others in an effort to find new ways to prevent mosquitoes from finding and biting people, and, ultimately, reduce the transmission of mosquito-borne diseases.
July 08, 2019
As antimicrobial resistance spreads among the world’s pathogens, NIAID is supporting research to find new uses for existing antibiotics. One such study is examining whether fosfomycin, an older antibiotic usually taken by mouth that has been approved for use in the United States for over 45 years, may also be given by IV infusion to treat bacterial infections in the lungs.
June 25, 2019
The intestinal parasite Cryptosporidium is an important cause of early childhood illness, growth-stunting and death around the world. Two advances in the lab make it easier to study the parasite and may lead to new drugs or vaccines.
June 20, 2019
The World Health Organization recently declared antibacterial resistance to be one of the top ten threats to global health. The NIAID-funded Antibacterial Resistance Leadership Group (ARLG) has established projects, networks, and partnerships that will assist scientists as they fight resistant bacteria.
June 11, 2019
A weapon made from spider toxin destroys blood-sucking enemies from the inside and helps save people from disease and death. It sounds like the plot of a superhero movie, but it’s actually a new way to combat malaria. NIAID-funded researchers who developed a genetically modified mosquito-killing fungus and tested it in the West African nation of Burkina Faso have shown that it even works against mosquitoes that have become resistant to chemical insecticides.
May 06, 2019
Around the world, bacteria are now developing resistance to many common antibiotics, which threatens their effectiveness and puts millions of lives at risk. NIAID Now spoke to Dr. Keith Kaye, the Principal Investigator of the OVERCOME trial, which focuses on the best ways to use antibiotics in order to increase their lifespans as useful treatment options.
April 12, 2019
Malaria is caused by a tiny parasite that infects human livers and red blood cells, and which is transmitted from person to person by a female mosquito. NIAID-funded researchers investigated how the parasite takes nutrients to complete completes critical life stages inside a mosquito without harming the mosquito's ability to lay eggs.
March 19, 2019
See new infographics from the Centers of Excellences for Influenza Research and Surveillance (CEIRS) network. NIAID established the CEIRS network in 2007 to continue and expand the fight against emerging and developing strains of flu. CEIRS now helps provide information and public health tools to control the threats of both epidemic and pandemic influenza.
March 01, 2019
Tickborne diseases are a growing problem in the United States. In response to recommendations from the Tick-borne Disease Working Group, the NIH is developing a strategic plan to advance tickborne disease research and development, and is seeking comments and suggestions from stakeholders throughout the scientific research, advocacy, and clinical practice communities, and the general public.
November 09, 2018
Even after standard antibiotic treatments, tuberculosis patients can relapse if not all the bacteria are killed. By re-examining patients’ sputum, or thick saliva, collected from other studies, NIAID-funded researchers found a way to determine whether patients are likely to relapse following standard treatment.
October 12, 2018
An advanced electron microscopy technique has given scientists a clearer picture of a molecule used by insects to smell their way around.
August 27, 2018
NIH Director Francis S. Collins, M.D., Ph.D., keeps the public posted on fascinating NIH-supported research in biweekly posts on the NIH Director's Blog. The blog features the work of scientists from many of NIH's institutes and centers, as well as NIH grantees and collaborators, and NIAID is no exception.
August 20, 2018
August 20 is World Mosquito Day. NIAID is part of the fight against these death-dealing insects.
August 14, 2018
NIAID supported the development of a new drug to treat smallpox, the first to be approved specifically to treat the viral disease.